product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Influenza A Matrix Protein
catalog :
MCA401
quantity :
1 mg
price :
660 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
GA2B
reactivity :
Alphainfluenzavirus, Influenza A virus (A/Puerto Rico/8/1934(H1N1))
application :
western blot, immunocytochemistry
more info or order :
citations: 16
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| |
| |
| |
| |
| |
Jimenez G, Planchon R, Wei Q, Rusalov D, Geall A, Enas J, et al. Vaxfectin-formulated influenza DNA vaccines encoding NP and M2 viral proteins protect mice against lethal viral challenge. Hum Vaccin. 2007;3:157-64 pubmed
|
image
image 1 :

Published customer image: . Mouse anti Influenza A Matrix Protein antibody, clone GA2B used for the evaluation of influenza matrix protein expression in infected cell lysates by western blotting. Image caption: . Tyrosine kinase activity is required for efficient uptake of IAV. (A, B, C) A549 cells were treated with genistein (50 uM, [+]) or (D, E) a mixture of several RTK inhibitors (each 10 uM, [+] see experimental procedures) or the solvent control (DMSO,[−]) respectively for 60 min at 37°C or over night prior to infection. (A) Upon genistein treatment, cells were either mock infected or infected with influenza virus A/FPV/Bratislava/79 (H7N7) (FPV; MOI = 100) for further 30 min. Virus particles were visualized in immunofluorescence (IF) microscopy, via a hemagglutinin (HA)-specific rabbit antiserum and an Alexa 594-conjugated chicken anti-rabbit IgG. The nuclei were stained with DAPI. The white arrowheads point to virus particles lining at the cell border. (B, D) After infection with influenza virus A/Puerto-Rico/8/34 (H1N1) PR8 (MOI = 8) for further 30 min, an acidic wash (PBS, pH 1.3, 4°C) was performed before cell-lysis. Internalized virus particles were visualized with a M1 monoclonal antibody in Western-blot (WB) analysis. Equal protein load was verified by ERK2 detection. The relative amount of M1 was quantified (B and D lower panels). Relative M1 densities are expressed as mean ±SD of three independent experiments. (C, E) Cells were infected with FPV or PR8 (MOI = 4) for 8 h; upon the virus-attachment period an acidic wash (PBS-HCl, pH 5.5) was included. Progeny virus titers were determined by standard plaque assays. Data represent mean values of at least three independent experiments ±SD. Statistical significance was assessed by student s t-test (*) p PLoS Pathog 6(9): e1001099 .
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA401
Description :
Mouse anti Influenza A Matrix Protein
Specificity :
Influenza A Matrix Protein
TargetSpecies :
Viral
Host :
Mouse
Format :
Purified
Isotypes :
IgG1
Applications :
WB,P,IF
ApplicationTypes :
Western Blotting,Immunohistology - Paraffin,Immunofluorescence
Clone :
GA2B
Quantity :
1 mg
Quantity Value :
1
Quantity Type :
mg
GO Accessions :
GO:0005886,GO:0003723,GO:0005829,GO:0005198,GO:0005654,GO:0019064,GO:0019061,GO:0019065,GO:0019070,GO:0019072,GO:0019076,GO:0019083,GO:0030666,GO:0030683,GO:0031904,GO:0042025,GO:0046796,GO:0055036,GO:0016020
GOTerms :
plasma membrane,RNA binding,cytosol,structural molecule activity,nucleoplasm,viral envelope fusion with host membrane,uncoating of virus,receptor-mediated endocytosis of virus by host,viral genome maturation,viral genome packaging,release of virus from host,viral transcription,endocytic vesicle membrane,evasion by virus of host immune response,endosome lumen,host cell nucleus,viral genome transport in host cell,virion membrane,membrane
Uniprot Accessions :
P03485,P03487
Gene :
M1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=956527
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
471
PriceEUR :
660
PriceUSD :
660 USD
PriceCHF :
718
PriceSEK :
7194
PriceNOK :
7230
PriceDKK :
4921
NotForSaleInCountries :
AU
more info or order :
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.